Safety tolerability and impact on viral reservoirs of the addition to antiretroviral therapy of ABX464 an investigational antiviral drug in individuals living with HIV-1: a Phase IIa randomised controlled study

摘要

ObjectivesTo assess the safety and tolerability as well as antiretroviral impact of ABX464, an oral investigational drug with a novel mechanism of HIV-1 inhibition (ClinicalTrials.gov ).